Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jackson T Wright

Showing results (101-110 of 189) with videos related to

Pageof 19
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|October 18, 2018
Prognostic relevance of visit-to-visit office blood pressure variability in Systolic Blood Pressure Intervention Trial: Same data, different conclusions?Tara I Chang, David M Reboussin, Glenn M Chertow, et al.
Hypertension (Dallas, Tex. : 1979)|December 30, 2015
Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort StudyGeorge Thomas, Dawei Xie, Hsiang-Yu Chen, et al.
Journal of the American Society of Hypertension : JASH|September 27, 2016
Orthostatic changes in systolic blood pressure among SPRINT participants at baselineRaymond R Townsend, Tara I Chang, Debbie L Cohen, et al.
Hypertension (Dallas, Tex. : 1979)|February 20, 2019
Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney DiseaseJing Chen, Joshua D Bundy, L Lee Hamm, et al.
Journal of General Internal Medicine|August 9, 2022
Intensive Versus Standard Blood Pressure Lowering and Days Free of Cardiovascular Events and Serious Adverse Events: a Post Hoc Analysis of Systolic Blood Pressure Intervention TrialDae Hyun Kim, Curtis Tatsuoka, Zhengyi Chen, et al.
Journal of the American Society of Nephrology : JASN|September 25, 2010
Malnutrition-inflammation modifies the relationship of cholesterol with cardiovascular diseaseGabriel Contreras, Bo Hu, Brad C Astor, et al.
Annals of Internal Medicine|February 17, 2015
Time-updated systolic blood pressure and the progression of chronic kidney disease: a cohort studyAmanda H Anderson, Wei Yang, Raymond R Townsend, et al.
American Journal of Preventive Cardiology|March 17, 2025
The community health worker model for cardiovascular kidney metabolic syndrome: A new paradigm for high value careSanjay Rajagopalan, Jeshurun Adarquah-Yiadom, Fonda Mcclain, et al.
American Journal of Hypertension|August 6, 2002
Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For EndpointPeter M Okin, Jackson T Wright, Markku S Nieminen, et al.
American Heart Journal|June 24, 2010
Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC)Elsayed Z Soliman, Ronald J Prineas, Alan S Go, et al.
Pageof 19

Showing results (101-110 of 189) with videos related to

Sort By:
Pageof 19
Journal of Clinical Hypertension (Greenwich, Conn.)|October 18, 2018
Prognostic relevance of visit-to-visit office blood pressure variability in Systolic Blood Pressure Intervention Trial: Same data, different conclusions?Tara I Chang, David M Reboussin, Glenn M Chertow, et al.
Hypertension (Dallas, Tex. : 1979)|December 30, 2015
Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort StudyGeorge Thomas, Dawei Xie, Hsiang-Yu Chen, et al.
Journal of the American Society of Hypertension : JASH|September 27, 2016
Orthostatic changes in systolic blood pressure among SPRINT participants at baselineRaymond R Townsend, Tara I Chang, Debbie L Cohen, et al.
Hypertension (Dallas, Tex. : 1979)|February 20, 2019
Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney DiseaseJing Chen, Joshua D Bundy, L Lee Hamm, et al.
Journal of General Internal Medicine|August 9, 2022
Intensive Versus Standard Blood Pressure Lowering and Days Free of Cardiovascular Events and Serious Adverse Events: a Post Hoc Analysis of Systolic Blood Pressure Intervention TrialDae Hyun Kim, Curtis Tatsuoka, Zhengyi Chen, et al.
Journal of the American Society of Nephrology : JASN|September 25, 2010
Malnutrition-inflammation modifies the relationship of cholesterol with cardiovascular diseaseGabriel Contreras, Bo Hu, Brad C Astor, et al.
Annals of Internal Medicine|February 17, 2015
Time-updated systolic blood pressure and the progression of chronic kidney disease: a cohort studyAmanda H Anderson, Wei Yang, Raymond R Townsend, et al.
American Journal of Preventive Cardiology|March 17, 2025
The community health worker model for cardiovascular kidney metabolic syndrome: A new paradigm for high value careSanjay Rajagopalan, Jeshurun Adarquah-Yiadom, Fonda Mcclain, et al.
American Journal of Hypertension|August 6, 2002
Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For EndpointPeter M Okin, Jackson T Wright, Markku S Nieminen, et al.
American Heart Journal|June 24, 2010
Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC)Elsayed Z Soliman, Ronald J Prineas, Alan S Go, et al.
Pageof 19